Market Research Future

World Nutrigenomics Market Key Players Revenue, Shares, Analysis and Forecasts 2017 to 2023

The World Nutrigenomics Market central point contributing for the development of the market are raising diabetic and large populace, expanding applications in dermatology, and expanding interest for the progressed symptomatic strategies.


Pune, India -- (SBWIRE) -- 12/08/2017 -- The Global Nutrigenomics Market report has been segmented on the basis of products, techniques and application. On the basis of products, the market is categorized into reagents & kits, services. The Global Nutrigenomics Market report summarizes bits of knowledge about elements influencing the market development and examinations the market structure alongside estimate for the following 7 years of the different fragments and sub-sections of the Nutrigenomics showcase. On the basis of application the market is segmented into obesity, diabetes, anti-aging and chronic diseases. On the basis of techniques, the market is segmented into saliva, buccal swab, blood, others.

Exclusive Sample Copy @ .

The Worldwide Nutrigenomics Market is required to develop at the CAGR of 16.8% amid the conjecture time frame and is assessed to achieve USD 17,313.5 million by 2023. Nutrigenomics is the investigation of communication of supplement and qualities. It ponders the impact of sustenance and their constituents on the qualities.

Nutrigenomics Market Key Players are:

WellGen Inc. (US),

Metagenics, Inc (US),

Genomix Nutrition, Inc. (US),

Nutrigenomix (US),

NutraGene (India),

XCODE Life Sciences Pvt. Ltd. (India),

Cura Integrative Medicine (Australia).

Nutrigenomics Market Regional Analysis: Considering the global scenario of the market, America dominates the global nutrigenomics market owing to the presence of huge population suffering from diabetes and obesity. North America holds the largest market share in America nutrigenomics market. According to the Centers for Disease Control and Prevention (2015), in America approximately 9.3% of the total America population is suffering from diabetes.

Europe has the second largest market for the Nutrigenomics Industry which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the nutrigenomics market in Europe is growing at a CAGR of 17%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge diabetic and obese population and rising healthcare expenditure.

Order a Single User License Copy of 94 Premium Pages Report Enabled with respective Tables and Figures is Available @ .

Asia Pacific Nutrigenomics Industry is expected to grow at a CAGR of 17.1% during the forecasted period. The Middle East & Africa is expected to have limited growth. Middle East is dominating this market by holding 64.3% of the Middle East & Africa market share.

According to the International Diabetes Federation (2016), 420 million adults were suffering from diabetes which is expected to reach 625 million by 2040. Further, as per the World Health Organization (2014), more than 600 million adults were obese and 1.9 billion adults, were overweight. Moreover, increasing healthcare expenditure, and government support for research & development has fueled the market growth. However, high cost of treatment and need of well qualified physicians may restrain the growth of market.

Major TOC Nutrigenomics Market:
1 Report Prologue
2 Introduction

2.1 Scope of Study

2.2 Research Objective

2.3 Assumptions & Limitations

2.3.1 Assumptions

2.3.2 Limitations

2.4 Market Structure
3 Research Methodology

3.1 Market Size Estimation

3.1.1 Market Share analysis

3.2 Market Pricing Approach


Ask to Expertise @ .

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.